HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,715,000 | -38.7% | 63,820 | -31.8% | 0.33% | -37.6% |
| Q1 2020 | $9,322,000 | -31.1% | 93,540 | -20.6% | 0.53% | -42.2% |
| Q4 2019 | $13,527,000 | -14.8% | 117,740 | -6.4% | 0.91% | -18.4% |
| Q3 2019 | $15,875,000 | -1.3% | 125,840 | -5.9% | 1.12% | +1.1% |
| Q2 2019 | $16,089,000 | +37.0% | 133,700 | -0.4% | 1.10% | +24.3% |
| Q1 2019 | $11,744,000 | -28.3% | 134,260 | -18.0% | 0.89% | -39.3% |
| Q4 2018 | $16,371,000 | -14.3% | 163,651 | -1.8% | 1.46% | +9.0% |
| Q3 2018 | $19,093,000 | +26.1% | 166,648 | -1.3% | 1.34% | +23.6% |
| Q2 2018 | $15,138,000 | +34.6% | 168,800 | +9.8% | 1.09% | +34.2% |
| Q1 2018 | $11,250,000 | +490.6% | 153,800 | +368.9% | 0.81% | +495.6% |
| Q4 2017 | $1,905,000 | – | 32,800 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |